RE:RE:RE:RE:BNN Coverage of New CEONossy45 wrote:
Drug prices increases are actually baked into the UK agreement, it's not as if drug prices won't go up ... they will just go up something like 5 - 15 5 YOY versus what we had before. This is ridiculous, the sentiment is very very very very very bad but that's were the opportunity is ... CXR has very good assets ... especially internationally ... drugs all over asia, europe ... it's not as black and white as you think
What you have stated on drug pricing practices in the UK is inaccurate. You should not make statements on drug pricing without an examination of NHS Prescription Cost Analysis. Veritas Research has done an extensive analysis of AMCo's Key Drugs Levothyroxine Sodium, Nitrofurantoin, Prednisolone, Carbimazole, Liothyronine (*mentioned specifically in the House of Common by a member of parliament), Fusidic Acid, Erythromycin, Co-Cadamol and Tanylcypromine Sulfate. Shorts have a directional sence of what the porfolio looks like, and I doubt many are covering their position before Q3. Good luck.